MILLENNIAL SCIENTIFIC

Live / Registered — Registered (as of 16 Aug 2022)

What this means for you

Registered since 16 Aug 2022. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90033722
Registration number
6817150
Mark type
Stylized text
Filed
02 Jul 2020
Published for opposition
31 May 2022
Registered
16 Aug 2022

Goods and services

  • Class 001 — Chemicals: Antioxidants for use in the manufacture of pharmaceuticals; Biometallic compounds for use in the manufacture of pharmaceutical preparations; Chemical additives for use in the manufacture of pharmaceuticals; Dendrimer-based polymers for use in the manufacture of capsules for pharmaceuticals; Diamond molecules and derivatives for use in nanotechnology, microelectronics, optics, and pharmaceuticals; Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals; Perfluorinated chemical compounds prepared synthetically for use in the manufacture of cosmetics and pharmaceuticals; Phenothiazine for use as a pharmaceutical intermediate; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical devices, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Polyvinyl alcohol soluble films for use in the manufacture of delivery agents for pharmaceuticals, breath freshener, vitamins, and candy; Preservatives for use in the pharmaceutical industry; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Vitamins for use in the manufacture of pharmaceuticals
  • Class 009 — Scientific and electric apparatus: Pharmaceutical and scientific research equipment for use in mass spectrometers; Pressure regulators for chromatography separation and purification columns
  • Class 042 — Scientific and technological services: Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Conducting early evaluations in the field of new pharmaceuticals; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Owner

Prosecution history

  • 16 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 16 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
  • 31 May 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 31 May 2022 — PUBLISHED FOR OPPOSITION
  • 11 May 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 28 Apr 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 28 Apr 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 28 Apr 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 26 Apr 2022 — ASSIGNED TO LIE
  • 19 Apr 2022 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
  • 18 Apr 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 18 Apr 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 18 Apr 2022 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
  • 24 Feb 2022 — NOTIFICATION OF SUBSEQUENT FINAL EMAILED
  • 24 Feb 2022 — CONTINUATION OF FINAL REFUSAL E-MAILED

View this trademark record on Marksy